Travere Therapeutics, Inc.

TVTXNASDAQ

Market cap5.85B USDAs of Sep 22, 2026

Healthcare· Biotechnology· US

$62.86

Session change unavailable

Market closed · NASDAQ

Status checked Oct 24, 2026, 11:39 PM · America/New_York

Observed Sep 21, 2026, 8:00 PM UTC · Last available price

Travere Therapeutics, Inc. (TVTX)

Loading market observation…

Current source feed

SEC filings

Company news and regulatory filings are separate evidence streams. Items are sorted newest first and duplicate URLs, same-day headlines, filing accessions and filing forms are collapsed before display.

SEC filings

Regulatory filings · separate from news

10 unique

4
Filed Sep 17, 2026 · Source: SEC document
Open filing
4
Filed Sep 17, 2026 · Source: SEC document
Open filing
4
Filed Sep 17, 2026 · Source: SEC document
Open filing
4
Filed Sep 17, 2026 · Source: SEC document
Open filing
4
Filed Sep 17, 2026 · Source: SEC document
Open filing
4
Filed Sep 17, 2026 · Source: SEC document
Open filing
4
Filed Sep 17, 2026 · Source: SEC document
Open filing
4
Filed Sep 11, 2026 · Source: SEC document
Open filing
4
Filed Sep 3, 2026 · Source: SEC document
Open filing
4
Filed Aug 19, 2026 · Source: SEC document
Open filing

Travere Therapeutics, Inc. research

Loading research…

Model estimates are informational, not investment advice. They are uncertain, may be wrong, and do not guarantee future prices.